Crisis in Access to Essential Medicines in India: Key Issues for Action
An Unethical and Unwanted Assurance
Cleaning up the Pharma Industry: Ban on Irrational FDCs
A Law that Needs Much more than a Cosmetic Change?
Is the Government Mulling a Surgical strike on Medicines?
Prescribing Generic Medicines
Indian Govt may ask Doctors to Prescribe Medicines under Generic Name: Is it Practical?
What's in a Generic Name
Obituary Dr Ranjit Roy Chaudhury
Ethical Minefield: Pharma Industry's Gifts to Doctors
AIDAN Press Release on Generic Precriptions
Quality, Safety and Efficacy of Drugs
The Impact of GST on Medicine Prices
Misreading the Pharma Market
How to make the new Pharma Price Index a Healthy Model
Not the Right Prescription for Affordable Healthcare
FDC Ban and Endless Rounds of Litigation
FDCs and their Ban: Issues of Concern
Bad news for Patients as the Govt Weakens the Drug Price Regulator and meddles with Price Caps
Anticancer Drugs: Capping Trade Margins is not Enough
India's New Clinical Trial Rules weakens Safety Nets for Participants
Manifestos Duck Core Pharma Issues
The bitter side of India’s pharma story
The Oxytocin Ban: Judgment and Legal Issues
Of judicial reviews, legislative decisions and scientific matters
CHIM Method of Vaccine Testing is no shot in the arm for India
Oxytocin Case - the issues and the High Court and Supreme Court order
HCQ Diplomacy
Healthcare should always be available
The vaccine mandates judgment: some reflections
Why do unethical pharma practices thrive?
